[1]
“Ki-67 Index and Somatostatin Receptor Expression as Prognostic Markers in Patients with Pancreatic Neuroendocrine Tumours: A Review”, AGDD, vol. 8, no. 1, pp. 5–9, Jul. 2025, Accessed: Sep. 12, 2026. [Online]. Available: https://somatopub.com/index.php/AGDD/article/view/302